{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:07:18Z","timestamp":1788444438353,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd011005","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,1,2]],"date-time":"2018-01-02T00:00:00Z","timestamp":1514851200000}}],"reference-count":55,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011005.pub2","type":"journal-article","created":{"date-parts":[[2018,1,2]],"date-time":"2018-01-02T14:52:01Z","timestamp":1514904721000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Treatment of fatigue in amyotrophic lateral sclerosis\/motor neuron disease"],"prefix":"10.1002","volume":"2018","author":[{"given":"Chris","family":"Gibbons","sequence":"first","affiliation":[{"name":"University of Cambridge; The Primary Care Unit; Forvie Site Robinson Way Cambridge Cambridgeshire UK CB2 0SR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pagnini","sequence":"additional","affiliation":[{"name":"Universit\u00e0 Cattolica del Sacro Cuore; Department of Psychology; Via Nirone 15, Milano Italy 20123"},{"name":"Harvard University; Department of Psychology; Cambridge Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Friede","sequence":"additional","affiliation":[{"name":"University Medical Center Goettingen; Department of Medical Statistics; Goettingen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn A","family":"Young","sequence":"additional","affiliation":[{"name":"The Walton Centre NHS Foundation Trust; Lower Lane Fazakerley Liverpool UK L9 7LJ"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,1,2]]},"reference":[{"issue":"23","key":"10.1002\/14651858.CD011005.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1212\/01.wnl.0000264418.92308.a4","article-title":"A randomized controlled trial of resistance exercise in individuals with ALS","volume":"68","author":"Dal Bello-Haas","year":"2007","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD011005.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/17482968.2011.626052","article-title":"Respiratory exercise in amyotrophic lateral sclerosis","volume":"13","author":"Pinto","year":"2012","journal-title":"Amyotrophic Lateral Sclerosis"},{"issue":"3","key":"10.1002\/14651858.CD011005.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/mus.21245","article-title":"Modafinil treatment of fatigue in patients with ALS: a placebo-controlled study","volume":"39","author":"Rabkin","year":"2009","journal-title":"Muscle & Nerve"},{"issue":"1-2","key":"10.1002\/14651858.CD011005.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jns.2008.01.011","article-title":"The effect of repetitive transcranial magnetic stimulation on motor performance, fatigue and quality of life in amyotrophic lateral sclerosis","volume":"270","author":"Zanette","year":"2008","journal-title":"Journal of the Neurological Sciences"},{"issue":"3","key":"10.1002\/14651858.CD011005.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/CND.0b013e3182095b2b","article-title":"Effects of 3-4 diaminopyridine (DAP) in motor neuron diseases","volume":"12","author":"Bertorini","year":"2011","journal-title":"Jounal of Clinical Neuromuscular Disease"},{"issue":"1","key":"10.1002\/14651858.CD011005.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/104990910502200112","article-title":"Modafinil to treat fatigue in amyotrophic lateral sclerosis: an open label pilot study","volume":"22","author":"Carter","year":"2005","journal-title":"American Jounal of Hospice and Palliative Medicine"},{"issue":"4","key":"10.1002\/14651858.CD011005.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1212\/WNL.61.4.456","article-title":"A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis","volume":"61","author":"Cudkowicz","year":"2003","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD011005.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/146608201300079364","article-title":"A double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. ALS riluzole-tocopherol Study Group","volume":"2","author":"Desnuelle","year":"2001","journal-title":"Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders"},{"issue":"1-2","key":"10.1002\/14651858.CD011005.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0022-510X(01)00610-4","article-title":"The value of muscle exercise in patients with amyotrophic lateral sclerosis","volume":"191","author":"Drory","year":"2001","journal-title":"Journal of the Neurological Sciences"},{"issue":"6","key":"10.1002\/14651858.CD011005.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"e37885","DOI":"10.1371\/journal.pone.0037885","article-title":"A randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosis","volume":"7","author":"Dupuis","year":"2012","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1002\/14651858.CD011005.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/jnnp.58.2.201","article-title":"Continuous response variable trial design in motor neuron disease: long term treatment with a TRH analogue (RX77368)","volume":"58","author":"Goonetilleke","year":"1995","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD011005.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(07)70270-3","article-title":"Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial","volume":"6","author":"Gordon","year":"2007","journal-title":"Lancet Neurology"},{"issue":"6","key":"10.1002\/14651858.CD011005.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1212\/01.wnl.0000237439.78935.46","article-title":"High-frequency chest wall oscillation in ALS","volume":"67","author":"Lange","year":"2006","journal-title":"Neurology"},{"issue":"1-2","key":"10.1002\/14651858.CD011005.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0022-510X(01)00611-6","article-title":"Effects of creatine supplementation on exercise performance and muscular strength in amyotrophic lateral sclerosis: preliminary results","volume":"191","author":"Mazzini","year":"2001","journal-title":"Journal of the Neurological Sciences"},{"issue":"5","key":"10.1002\/14651858.CD011005.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1080\/17482960802028890","article-title":"Creatine monohydrate in ALS: effects on strength, fatigue, respiratory status and ALSFRS","volume":"9","author":"Rosenfeld","year":"2009","journal-title":"Amyotrophic Lateral Sclerosis"},{"issue":"Suppl. 1","key":"10.1002\/14651858.CD011005.pub2-BIB0016|cit16","first-page":"191","article-title":"Effects of a hydrotherapy program on function and muscle strength in patients with sporadic amyotrophic lateral sclerosis","volume":"10","author":"Silva","year":"2009","journal-title":"Amyotrophic Lateral Sclerosis"},{"issue":"4","key":"10.1002\/14651858.CD011005.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/14660820410021285","article-title":"A Phase I safety study of hyperbaric oxygen therapy for amyotrophic lateral sclerosis","volume":"5","author":"Steele","year":"2004","journal-title":"Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders"},{"issue":"1","key":"10.1002\/14651858.CD011005.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0272-7358(88)90050-5","article-title":"Psychometeric properties of the Beck Depression Inventory-25 years of evaluation","volume":"8","author":"Beck","year":"1988","journal-title":"Clinical Psychology Review"},{"issue":"23","key":"10.1002\/14651858.CD011005.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1212\/01.wnl.0000264418.92308.a4","article-title":"A randomised controlled trial of resistance exercise in individuals with ALS","volume":"68","author":"Bello-Haas","year":"2007","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD011005.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/14660820410020330","article-title":"Non-invasive ventilation in ALS: current practice and future role","volume":"5","author":"Bourke","year":"2004","journal-title":"Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders"},{"issue":"5","key":"10.1002\/14651858.CD011005.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/146608200300079536","article-title":"El Escorial revised: revised criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders"},{"key":"10.1002\/14651858.CD011005.pub2-BIB0022|cit22","doi-asserted-by":"crossref","unstructured":"Cedarbaum JM Stambler N Malta E Fuller C Thurmond B Nakanishi A The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III) Journal of the Neurological Sciences 1999 13 21","DOI":"10.1016\/S0022-510X(99)00210-5"},{"issue":"3","key":"10.1002\/14651858.CD011005.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/026921639500900306","article-title":"The McGill Quality of Life Questionnaire: a measure of quality of life appropriate for people with advanced disease. A preliminary study of validity and acceptability","volume":"9","author":"Cohen","year":"1995","journal-title":"Palliative Medicine"},{"issue":"14","key":"10.1002\/14651858.CD011005.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"967","DOI":"10.2165\/00023210-200418140-00002","article-title":"The role of creatine in the management of amyotrophic lateral sclerosis and other neurodegenerative disorders","volume":"18","author":"Ellis","year":"2004","journal-title":"CNS Drugs"},{"key":"10.1002\/14651858.CD011005.pub2-BIB0025|cit25","first-page":"12","article-title":"Validation of a shorter ALS-specific quality of life instrument: the ALSSQOL-R","volume":"9 Suppl 1","author":"Felgoise","year":"2008","journal-title":"Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders"},{"key":"10.1002\/14651858.CD011005.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"s79","DOI":"10.1093\/clinids\/18.Supplement_1.S79","article-title":"Measuring the functional impact of fatigue: initial validation of the fatigue impact scale","volume":"18 Suppl 1","author":"Fisk","year":"1994","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD011005.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1477-7525-9-101","article-title":"Development of a patient-reported outcome measure for fatigue in motor neurone disease: the Neurological Fatigue Index (NFI-MND)","volume":"9","author":"Gibbons","year":"2011","journal-title":"Health and Quality of Life Outcomes"},{"issue":"788","key":"10.1002\/14651858.CD011005.pub2-BIB0028|cit28","first-page":"1","article-title":"The patient experience of fatigue in motor neurone disease","volume":"4","author":"Gibbons","journal-title":"Frontiers in Psychology"},{"issue":"7-8","key":"10.1002\/14651858.CD011005.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3109\/21678421.2013.799700","article-title":"The impact of fatigue and psychosocial variables on quality of life for patients with motor neuron disease","volume":"14","author":"Gibbons","year":"2013","journal-title":"Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration"},{"key":"10.1002\/14651858.CD011005.pub2-BIB0030|cit30","unstructured":"Jan Brozek, Andrew Oxman, Holger Sch\u00fcnemann GRADEpro 2008"},{"issue":"5","key":"10.1002\/14651858.CD011005.pub2-BIB0031|cit31","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008554.pub2","article-title":"Repetitive transcranial magnetic stimulation for the treatment of amyotrophic lateral sclerosis or motor neuron disease","author":"Guo","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011005.pub2-BIB0032|cit32","unstructured":"Higgins JPT Altman DG Sterne JAC Chapter 8: Assessing risk of bias in included studies. In Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"2-3","key":"10.1002\/14651858.CD011005.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejphar.2007.09.009","article-title":"Involvement of central histaminergic systems in modafinil-induced but not methylphenidate-induced increases in locomotor activity in rats","volume":"578","author":"Ishizuka","year":"2008","journal-title":"European Journal of Pharmacology"},{"key":"10.1002\/14651858.CD011005.pub2-BIB0034|cit34","first-page":"649","article-title":"Symptomatic pharmacotherapy: bulbar and constitutional symptoms","volume-title":"Amyotrophic Lateral Sclerosis","author":"Jackson","year":"2006"},{"issue":"6","key":"10.1002\/14651858.CD011005.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the Epworth sleepiness scale","volume":"14","author":"Johns","year":"2001","journal-title":"Sleep"},{"issue":"1","key":"10.1002\/14651858.CD011005.pub2-BIB0036|cit36","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004030.pub3","article-title":"Enteral tube feeding for amyotrophic lateral sclerosis\/motor neuron disease","author":"Katzberg","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD011005.pub2-BIB0037|cit37","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004760.pub4","article-title":"Creatine for treating muscle disorders","author":"Kley","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD011005.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","article-title":"The Fatigue Severity Scale. Application to patients with multiple sclerosis and systemic lupus-erythematosus","volume":"46","author":"Krupp","year":"1989","journal-title":"Archives of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD011005.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1468-1331.2011.03637.x","article-title":"Fatigue, sleep, and nocturnal complaints in patients with amyotrophic lateral sclerosis","volume":"19","author":"Lo Coco","year":"2012","journal-title":"European Journal of Neurology"},{"issue":"4","key":"10.1002\/14651858.CD011005.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/jnnp.2009.183525","article-title":"Incidence of amyotrophic lateral sclerosis in Europe","volume":"81","author":"Logroscino","year":"2010","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD011005.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1212\/01.WNL.0000042781.22278.0A","article-title":"Fatigue and depression are associated with poor quality of life in ALS","volume":"60","author":"Lou","year":"2003","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD011005.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pmr.2011.11.003","article-title":"Techniques in assessing fatigue in neuromuscular diseases","volume":"23","author":"Lou","year":"2012","journal-title":"Physical Medicine and Rehabilitation Clinics of North America"},{"issue":"10","key":"10.1002\/14651858.CD011005.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1136\/jnnp.2008.163246","article-title":"Prevalence of fatigue and depression in ALS patients and change over time","volume":"80","author":"McElhiney","year":"2009","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD011005.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1212\/WNL.47.2.571","article-title":"Incidence of amyotrophic lateral sclerosis in three counties in western Washington State","volume":"47","author":"McGuire","year":"1996","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD011005.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/qjmed\/hcm122","article-title":"A medical definition of fatigue in multiple sclerosis","volume":"101","author":"Mills","year":"2008","journal-title":"QJM. Monthly Journal of the Association of Physicians"},{"issue":"10","key":"10.1002\/14651858.CD011005.pub2-BIB0046|cit46","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004427.pub4","article-title":"Mechanical ventilation for amyotrophic lateral sclerosis\/motor neuron disease","author":"Radunovic","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD011005.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/17482960701642502","article-title":"Fatigue in amyotrophic lateral sclerosis: frequency and associated factors","volume":"9","author":"Ramirez","year":"2008","journal-title":"Amyotrophic Lateral Sclerosis"},{"issue":"5","key":"10.1002\/14651858.CD011005.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1080\/17482960802028890","article-title":"Creatine monohydrate in ALS: effects on strength, fatigue, respiratory status and ALSFRS","volume":"9","author":"Rosenfeld","year":"2008","journal-title":"Amyotrophic Lateral Sclerosis"},{"issue":"22","key":"10.1002\/14651858.CD011005.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM200105313442207","article-title":"Medical progress: amyotrophic lateral sclerosis","volume":"344","author":"Rowland","year":"2001","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1002\/14651858.CD011005.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/j.apmr.2010.08.009","article-title":"Supported treadmill ambulation for amyotrophic lateral sclerosis: a pilot study","volume":"91","author":"Sanjak","year":"2010","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"key":"10.1002\/14651858.CD011005.pub2-BIB0051|cit51","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JPT Deeks JJ Glasziou P Guyatt GH Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"issue":"7191","key":"10.1002\/14651858.CD011005.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1136\/bmj.318.7191.1118","article-title":"Motor neurone disease","volume":"318","author":"Shaw","year":"1999","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD011005.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Medical Care"},{"issue":"6","key":"10.1002\/14651858.CD011005.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The Hospital Anxiety and Depression Scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"3","key":"10.1002\/14651858.CD011005.pub2-BIB0055|cit55","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011005","article-title":"Treatment for fatigue in amyotrophic lateral sclerosis\/motor neuron disease (ALS\/MND)","author":"Young","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD011005.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T07:13:42Z","timestamp":1650352422000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011005.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Neuromuscular Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,1,2]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011005.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,2]]}}}